Neonc Technologies (NASDAQ:NTHI) Stock: Insider Amir Heshmatpour Purchases 20,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour bought 20,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were purchased at an average price of $4.25 per share, with a total value of $85,000.00. Following the completion of the acquisition, the chief executive officer directly owned 3,333,000 shares in the company, valued at $14,165,250. This trade represents a 0.60% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Neonc Technologies Price Performance

Shares of NASDAQ:NTHI opened at $4.52 on Thursday. The company’s 50 day moving average is $3.30 and its two-hundred day moving average is $5.31. Neonc Technologies Holdings, Inc. has a 52 week low of $2.50 and a 52 week high of $12.00.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Analyst Ratings Changes

A number of brokerages have weighed in on NTHI. Zacks Research raised Neonc Technologies from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 5th. Weiss Ratings downgraded Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 21st. BTIG Research reiterated a “buy” rating and set a $15.00 target price on shares of Neonc Technologies in a report on Tuesday, September 8th. Roth Capital assumed coverage on shares of Neonc Technologies in a research report on Thursday, September 24th. They issued a “buy” rating for the company. Finally, Wall Street Zen raised shares of Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Institutional Investors Weigh In On Neonc Technologies

Several institutional investors have recently bought and sold shares of NTHI. Bank of America Corp DE acquired a new position in Neonc Technologies during the second quarter worth about $1,017,000. BlackRock Inc. purchased a new position in Neonc Technologies during the 2nd quarter valued at about $815,000. Global Retirement Partners LLC purchased a new position in shares of Neonc Technologies during the 2nd quarter valued at $126,000. Finally, Westmount Partners LLC increased its position in Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after purchasing an additional 153,858 shares during the last quarter.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.